Abstract:Background: Chronic kidney disease (CKD) and heart failure (HF) are interrelated conditions that exacerbate each other through mechanisms like fluid retention, neurohormonal activation, and inflammation. Red blood cell distribution width (RDW), a measure of red blood cell size variability, has emerged as a potential prognostic marker in HF. This study aimed to assess the prognostic value of RDW in HF patients, both with and without CKD, focusing on all-cause mortality and HF rehospitalizations. Methods: This observational retrospective study included 171 patients hospitalized for acute decompensated HF in a tertiary university hospital in Greece. Patients were divided into two groups based on their estimated glomerular filtration rate (eGFR), as Group 1 (eGFR < 60 mL/min/1.73 m2) and Group 2 (eGFR ≥ 60 mL/min/1.73 m2). RDW was measured upon admission, and outcomes of interest were all-cause mortality and HF rehospitalizations over a median follow-up period of 6.1 months. Statistical analyses included Kaplan–Meier survival curves, whereas the discrimination traits of RDW were evaluated by constructing receiver operating characteristic (ROC) curves and by calculating the area under the ROC curve (AUC). A p-value <0.05 was indicative of a statistically important result. Results: Patients in Group 1 (eGFR < 60 mL/min/1.73 m2) were older (80 (73–86) vs. 75 (62–83)) and manifested higher median RDW values (16.6 (15.0–18.8) vs. 15.6 (14.1–17.8)) and received less frequent (57.9% vs. 75%) mineralocorticoid receptor antagonists (MRAs) as compared to those in Group 2 (eGFR ≥ 60 mL/min/1.73 m2). RDW demonstrated better prognostic value in predicting combined mortality and rehospitalization outcomes in Group 2 patients (area under the curve: 0.70; 95% CI (0.62–0.80)) compared to those in Group 1 (area under the curve: 0.53; 95% CI (0.35–0.72)). No statistically significant differences (p = 0.579) were observed in survival between patients with high (≥15%) and low (<15%) RDW values in the overall population, though trends favored worse outcomes with elevated RDW. Similarly, no significant differences (p = 0.374) were observed in survival between patients with high (Group 2) and low (Group 1) eGFR values. Conclusions: RDW appears to be a meaningful prognostic biomarker for HF patients, particularly in those without CKD. Further multicenter studies are needed to validate its clinical utility and potential for guiding treatment in this high-risk population.

Does red blood cell distribution width predict prognosis in metastatic renal cell carcinoma patients using first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy?

Preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma

Can platelet distribution width lymphocyte ratio be a novel biomarker for predicting survival in metastatic renal cell cancer?

The Value of Red Blood Cell Distribution Width in Diagnosis of Patients with Colorectal Cancer.

Preoperative Platelet Distribution Width Represents a Novel Prognostic Biomarker in Patients With Nonmetastatic Renal Cell Carcinoma: A Retrospective Clinical Analysis

Prognostic and predictive significance of VEGF, CD31, and Ang-1 in patients with metastatic clear cell renal cell carcinoma treated with first-line sunitinib

Red Cell Distribution Width is Associated with Presence, Stage, and Grade in Patients with Renal Cell Carcinoma

External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations

Prognostic significance of hemoglobin-to-red cell distribution width ratio in patients with metastatic renal cancer

Clinical Relevance of Red Blood Cell Distribution Width (RDW) in Endometrial Cancer: A Retrospective Single-Center Experience from Korea

Prognostic Role of Pretreatment Red Blood Cell Distribution Width in Patients with Cancer: A Meta-Analysis of 49 Studies

The Prognostic Role of RDW in Hospitalized Heart Failure Patients with and Without Chronic Kidney Disease

Red Blood Cell Distribution Width is Associated with Adverse Kidney Outcomes in Patients with Chronic Kidney Disease

High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse

Prognostic Value Of Red Blood Cell Distribution Width In Non-Cardiovascular Critically Or Acutely Patients: A Systematic Review

Elevated Red Blood Cell Distribution Width Contributes to Poor Prognosis in Patients Undergoing Resection for Nonmetastatic Rectal Cancer.

Pre-treatment Red Blood Cell Distribution Width Provides Prognostic Information in Multiple Myeloma.

Evaluation of pretreatment red cell distribution width in patients with multiple myeloma.

Red Cell Distribution Width-a Potential Prognostic Indicator for Colorectal Cancer Patients after Radical Resection in China.

Utility of Red Cell Distribution Width As a Diagnostic and Prognostic Marker in Non-Small Cell Lung Cancer

Prognostic value of pretreatment red blood cell distribution width in lung cancer: a meta-analysis.